论文部分内容阅读
内皮素(Endothelin, ET)是一组新近发现的具有生物学功能的多肽,具有强烈的缩血管作用,是影响肾脏的一个不可忽视因素。本文就慢性肾功能衰竭(CRF)患者透析治疗与非透析治疗,CRF各期及伴有高血压和血压正常的血浆ET水平变化作观察比较。现报告如下。
Endothelin (ET) is a group of newly discovered biologically functional peptides that have a strong vasoconstrictor effect and are an indispensable factor affecting the kidneys. In this paper, chronic renal failure (CRF) patients with dialysis treatment and non-dialysis treatment, CRF stages and associated with hypertension and normotensive plasma ET levels were observed and compared. The report is as follows.